Browse > Article
http://dx.doi.org/10.3340/jkns.2018.0101

Hemorrhagic Moyamoya Disease : A Recent Update  

Fujimura, Miki (Department of Neurosurgery, Kohnan Hospital)
Tominaga, Teiji (Department of Neurosurgery, Tohoku University)
Publication Information
Journal of Korean Neurosurgical Society / v.62, no.2, 2019 , pp. 136-143 More about this Journal
Abstract
Moyamoya disease (MMD) is a progressive cerebrovascular disease with unknown etiology, characterized by bilateral steno-occlusive changes at the terminal portion of the internal carotid artery and an abnormal vascular network formation at the base of the brain. MMD has an intrinsic nature to convert the vascular supply for the brain from internal carotid (IC) system to the external carotid (EC) system, as indicated by Suzuki's angiographic staging. Insufficiency of this 'IC-EC conversion system' could result not only in cerebral ischemia, but also in intracranial hemorrhage from inadequate collateral anastomosis, both of which represent the clinical manifestation of MMD. Surgical revascularization prevents cerebral ischemic attack by improving cerebral blood flow, and recent evidence further suggests that extracranial-intracranial bypass could powerfully reduce the risk of re-bleeding in MMD patients with posterior hemorrhage, who were known to have extremely high re-bleeding risk. Although the exact mechanism underlying the hemorrhagic presentation in MMD is undetermined, most recent angiographic analysis revealed the characteristic angio-architecture related to high re-bleeding risk, such as the extension and dilatation of choroidal collaterals and posterior cerebral artery involvement. We sought to update the current management strategy for hemorrhagic MMD, including the outcome of surgical revascularization for hemorrhagic MMD in our institute. Further investigations will clarify the optimal surgical strategy to prevent hemorrhagic manifestation in patients with MMD.
Keywords
Moyamoya disease; Hemorrhage; Revascularization surgery; Angiography;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Fujimura M, Funaki T, Houkin K, Takahashi JC, Kuroda S, Tomata Y, et al. : Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan adult moyamoya trial. J Neurosurg, 2018 [Epub ahead of print]
2 Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T : Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis 33 : 436-445, 2012   DOI
3 Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T : Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67 : 273-282, 2007   DOI
4 Fujimura M, Kaneta T, Shimizu H, Tominaga T : Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease. Neurosurg Rev 32 : 245-249, 2009   DOI
5 Sakata H, Fujimura M, Mugikura S, Sato K, Tominaga T : Local vasogenic edema without cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. J Stroke Cerebrovasc Dis 24 : e179-e184, 2015   DOI
6 Suzuki J, Takaku A : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 : 288-299, 1969   DOI
7 Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, et al. : Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan adult moyamoya trial. Stroke 47 : 37-43, 2016   DOI
8 Tashiro R, Fujimura M, Mugikura S, Niizuma K, Endo H, Endo T, et al. : Paradoxical association of symptomatic local vasogenic edema with global cerebral hypoperfusion after direct revascularization surgery for adult moyamoya disease. J Stroke Cerebrlvasc Dis, 2018 [Epub ahead of print]
9 Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, et al. : Minocycline prevents focal neurologic deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74 : 163-170; discussion 170, 2014   DOI
10 Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T : Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71 : 442-447, 2009   DOI
11 Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T : Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using Nisopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 68 : 957-964, 2011   DOI
12 Fujimura M, Shimizu H, Mugikura S, Tominaga T : Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 71 : 223-227, 2009   DOI
13 Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. : Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke 16 : 65-72, 2014   DOI
14 Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K : Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke 47 : 1930-1932, 2016   DOI
15 Tominaga T, Suzuki N, Miyamoto S, Koizumi A, Kuroda S, Takahashi JC, et al. : Recommendations for the management of moyamoya disease: a statement from research committee on spontaneous occlusion of the circle of Willis (moyamoya disease) [2nd Edition]. Surg Cereb Stroke 46 : 1-24, 2018   DOI
16 Tu XK, Fujimura M, Rashad S, Mugikura S, Sakata H, Niizuma K, et al. : Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'. Neurosurg Rev 40 : 507-512, 2017   DOI
17 Fujimura M, Tominaga T : Current status of revascularization surgery for moyamoya disease: special consideration for its 'internal carotidexternal carotid (IC-EC) conversion' as the physiological reorganization system. Tohoku J Exp Med 236 : 45-53, 2015   DOI
18 Fujimura M, Tominaga T : Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo) 52 : 327-332, 2012   DOI
19 Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T : Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 72 : 476-480, 2009   DOI
20 Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K, Tamaki N : Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study. Stroke 43 : 2610-2616, 2012   DOI
21 Yuan M, Liu ZQ, Wang ZQ, Li B, Xu LJ, Xiao XL : High-resolution MR imaging of the arterial wall in moyamoya disease. Neurosci Lett 584 : 77-82, 2015   DOI
22 Houkin K, Ishikawa T, Yoshimoto T, Abe H : Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99 Suppl 2 : S142-S145, 1997
23 Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. : Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan adult moyamoya trial. J Neurosurg 128 : 777-784, 2018   DOI
24 Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. : High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan adult moyamoya trial. J Neurosurg, 2018 [Epub ahead of print]
25 Funaki T, Takahashi JC, Yoshida K, Takagi Y, Fushimi Y, Kikuchi T, et al. : Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg 124 : 1766-1772, 2016   DOI
26 Hayashi K, Horie N, Izumo T, Nagata I : A nationwide survey on unilateral moyamoya disease in Japan. Clin Neurol Neurosurg 124 : 1-5, 2014   DOI
27 Hayashi T, Shirane R, Fujimura M, Tominaga T : Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr 6 : 73-81, 2010   DOI
28 Hwang JW, Yang HM, Lee H, Lee HK, Jeon YT, Kim JE, et al. : Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease. Br J Anaesth 110 : 773-779, 2013   DOI
29 Irikura K, Miyasaka Y, Kurata A, Tanaka R, Fujii K, Yada K, et al. : A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien) 138 : 1282-1286, 1996   DOI
30 Kaku Y, Morioka M, Ohmori Y, Kawano T, Kai Y, Fukuoka H, et al. : Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) 154 : 2151-2157, 2012   DOI
31 Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. : A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 56 : 34-40, 2011   DOI
32 Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, et al. : Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81 : 673-678, 2010   DOI
33 Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK : Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis 25 : 580-586, 2008   DOI
34 Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y, Research Committee on Moyamoya Disease in Japan : Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 38 : 1430-1435, 2007   DOI
35 Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y : Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36 : 2148-2153, 2005   DOI
36 Ryoo S, Cha J, Kim SJ, Choi JW, Ki CS, Kim KH, et al. : High-resolution magnetic resonance wall imaging findings of moyamoya disease. Stroke 45 : 2457-2460, 2014   DOI
37 Kuroda S, Kashiwazaki D, Akioka N, Koh M, Hori E, Nishikata M, et al. : Specific shrinkage of carotid forks in moyamoya disease: a novel key finding for diagnosis. Neurol Med Chir (Tokyo) 55 : 796-804, 2015   DOI
38 Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the japan adult moyamoya trial. Stroke 45 : 1415-1421, 2014   DOI
39 Morioka M, Hamada J, Kawano T, Todaka T, Yano S, Kai Y, et al. : Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 34 : 90-95, 2003   DOI
40 Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases : Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52 : 245-266, 2012   DOI